Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY

Keyphrases

• Health-related Quality of Life 100%
• Interleukin-1β 100%
• Improved Health 100%
• Sleep Quality 100%
• Phase III Clinical Trial 100%
• Rilonacept 100%
• Recurrent Pericarditis 100%
• Patient-Reported Outcomes Measurement Information System (PROMIS) 72%
• Randomized Withdrawal 36%
• Withdrawal Period 27%
• Symptom Severity 18%
• Placebo 18%
• Change Score 18%
• Pericarditis 18%
• Pericarditis Recurrence 18%
• Inflammation 9%
• Statistical Model 9%
• Recurrence Rate 9%
• Health Impact 9%
• Patient-reported Health 9%
• Physical Health 9%
• Sleep Effects 9%
• Descriptive Statistics 9%
• Unique Identifier 9%
• Emotional Health 9%
• Repeated Measures Analysis 9%
• General Health Status 9%
• Mixed Model Repeated Measures 9%

Medicine and Dentistry

• Interleukin 1 100%
• Pericarditis 100%
• Quality of Sleep 100%
• Clinical Trial 100%
• Quality of Life 100%
• Rilonacept 100%
• Patient-Reported Outcome 72%
• Recurrent Disease 36%
• Placebo 18%
• Cytokine 9%
• Health Status 9%
• Mixed Model 9%
• Interleukin 1beta 9%
• Emotional Stability 9%
• Interleukin-1 9%
• Interleukin 1alpha 9%

Nursing and Health Professions

• Quality of Life 100%
• Interleukin 1 100%
• Rilonacept 100%
• Pericarditis 100%
• Patient-Reported Outcome 72%
• Recurrent Disease 36%
• Placebo 18%
• Inflammation 9%
• Health Status 9%
• Interleukin 1beta 9%
• Interleukin 1alpha 9%